Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology
- Written by PR Newswire
- Traditional methods for evaluating therapeutic efficacy and cardiotoxicity often lead to high failure rates during clinical trials, resulting in significant development costs
- Human-specific diseases cannot be accurately modeled by animals, leading to limited medical options or advancements
- This new study leverages the capabilities of artificial...
